NCT00871520

Brief Summary

The accuracy of clinical survival estimates is tested in comparison to objective prognostic scores.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
612

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2008

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 30, 2009

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
4.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

August 23, 2016

Status Verified

August 1, 2016

Enrollment Period

3.7 years

First QC Date

March 27, 2009

Last Update Submit

August 22, 2016

Conditions

Cancer

Keywords

Palliative CarePredictive Value of TestsProspective StudiesSurvival AnalysisSurvival prediction

Outcome Measures

Primary Outcomes (1)

  • Survival

    6 months

Study Arms (1)

Palliative Therapy

Patients referred to the oncology / radiation oncology departments for palliative therapy.

Other: no specific interventions

Interventions

no specific interventionsOTHER

There are no specific interventions in this observational study

Palliative Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive unselected cancer patients referred for palliative treatment to one of the participating institutions.

You may qualify if:

  • oncologic disease confirmed
  • incurable locally advanced or metastatic disease
  • palliative treatment intended
  • age \> 18
  • able to understand the study protocol
  • able to complete the forms with assistance if necessary

You may not qualify if:

  • therapy with curative intent
  • regular clinical follow-up visit without disease progression
  • ongoing therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University Hospital Duesseldorf, Radiation Oncology Dept.

Düsseldorf, North Rhine-Westphalia, 40225, Germany

Location

Sana Kliniken Duesseldorf Benrath

Düsseldorf, North Rhine-Westphalia, 40593, Germany

Location

Sana Kliniken Duesseldorf Gerresheim, MVZ Onkologie

Düsseldorf, North Rhine-Westphalia, 40625, Germany

Location

Related Publications (1)

  • Gripp S, Moeller S, Bolke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M, Willers R. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007 Aug 1;25(22):3313-20. doi: 10.1200/JCO.2006.10.5411.

    PMID: 17664480BACKGROUND

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Stephan Gripp, Dr.

    Universtity Hospital Duesseldorf, Radiation Oncology Department

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2009

First Posted

March 30, 2009

Study Start

April 1, 2008

Primary Completion

December 1, 2011

Study Completion

August 1, 2016

Last Updated

August 23, 2016

Record last verified: 2016-08

Locations

DE(3)